Arrowhead Pharmaceuticals Aktie
51,88
EUR
-0,96
EUR
-1,82
%
61,56
USD
-1,37
USD
-2,18
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
| 12.02.18 | Arrowhead Pharmaceuticals Neutral | Cantor Fitzgerald | |
| 12.02.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
| 05.01.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
| 30.11.16 | Arrowhead Pharmaceuticals Mkt Perform | William Blair | |
| 30.11.16 | Arrowhead Pharmaceuticals Hold | Cantor Fitzgerald | |
| 30.11.16 | Arrowhead Pharmaceuticals Neutral | Chardan Capital Markets | |
| 09.10.14 | Arrowhead Pharmaceuticals Sector Perform | RBC Capital Markets |
Werbung
Werbung